"I would say the take-home message is that usage of this mobile health platform could potentially improve patient quality of life and compliance with recommendations," says Jenny Guo, MD.
In this video, Jenny Guo, MD, shares the take-home message from the 2024 American Urological Association Annual Meeting abstract, “Development of a novel mobile health platform for surveillance of kidney stone formers: 6-month preliminary analysis.” Guo is a urology resident at Northwestern University Feinberg School of Medicine.
I would say the take-home message is that usage of this mobile health platform could potentially improve patient quality of life and compliance with recommendations. However, it does appear that most of the participants in our study tended to be younger or very highly motivated to use mobile health technology to prevent future stone recurrences. And we did see a pretty low recruitment and higher dropout rates than expected. So that may also point toward the fact that patients may value in-person follow-up and just prefer to see somebody face to face. So we definitely need some further studies to refine this technology and to see if it will really be useful. It'd be interesting to see in 10 to 20 years down the line if there's a shift in attitude toward usage of mobile health technology in prevention of stones.
I always want to emphasize that kidney stones are very common in the US. They occur in about 1 out of 10 to 11 people, and patients who have 1 stone oftentimes will have a recurrence; 1 in 5 will have a recurrence, so it's always important to continue doing research to prevent stones in the future.
This transcription was edited for clarity.
Bundled payment program covers kidney stone care
July 22nd 2024"One day, we're going to have to move away from fee for service, so we'd be wise to try to navigate those waters ahead of time, so we're not left dealing with the aftermath when someone else has implemented it for us," says Ruchika Talwar, MD.
FDA grants 510(k) clearance to Ambu’s single-use ureteroscope
July 2nd 2024"This clearance in the US of our new ureteroscopy solution not only demonstrates a market expansion for Ambu; it is a testament to the progressive shift towards single-use solutions within the field of urology," says Britt Meelby Jensen.
Data support shock wave lithotripsy for pediatric patients with kidney stones
May 28th 2024Regarding patient-reported outcomes, those who underwent URS showed higher urinary symptoms, greater pain intensity, and greater pain interference at 1 week following surgery compared with those who underwent SWL.